Phase I Study [resa]
liposomal daunorubicin [antb, orch]
relapsed [tmco]
Refractory [ftcn]
acute [tmco]
Myeloid Leukemia [neop]
Daunorubicin [antb, orch]
Cytotoxic Agents [bacs, hops]
treatment [ftcn]
Acute myeloid leukaemia [neop]
Limited [ftcn]
Drug-induced [ftcn]
Cardiotoxicity [inpo]
depend [medd]
Cumulative Dose [cnce]
Administered [ftcn]
liposomal [lipd]
Encapsulation [phpr]
Daunorubicin [antb, orch]
DaunoXome [orch, phsu]
R- [spco]
Severe [qlco]
Side Effect [patf]
investigate [ftcn]
toxicity [qlco]
Patients [podg]
Conduct [inbe]
Phase I Trial [resa]
Including [ftcn]
Patients [podg]
Old [tmco]
relapsed [tmco]
Refractory [ftcn]
Acute myeloid leukaemia [neop]
Doses [qnco]
>90 [qnco]
mg ml [qnco]
Biweekly [tmco]
Patients [podg]
Age [orga]
Range [qnco]
Courses [tmco]
Administered [ftcn]
Patients [podg]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
Courses [tmco]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
Courses [tmco]
mg/m2 [qnco]
Courses [tmco]
>90 [qnco]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
Courses [tmco]
Cumulative Dose [cnce]
Administered [ftcn]
mg% [qnco]
Range [qnco]
Left ventricular ejection fraction [clna]
CLINICAL SIGNS [fndg]
symptoms [ftcn]
Heart failure [dsyn]
Note [clna]
Patients [podg]
Cumulative Dose [cnce]
mg% [qnco]
Pre-Existing Disease [rnlw]
Heart [bpoc]
High dose [qnco]
Cumulative [qlco]
Left ventricular ejection fraction [clna]
Note [clna]
Nausea [sosy]
Vomiting [sosy]
Alopecia [fndg]
Mucositis [patf]
Absent [qnco]
Patients [podg]
Myelosuppression [dsyn]
Transfusion [topp]
Support [medd]
treatment [ftcn]
Patients [podg]
reduction [npop]
Leukemic Blasts [lbpr]
Bone Marrow [tisu]
Patients [podg]
Excluded [idcn]
Acute myeloid leukaemia [neop]
progression [patf]
Course [tmco]
Patients [podg]
Died [orgf]
weeks [tmco]
treatment [ftcn]
conclude [bodm, orch]
toxic [inpo]
Alternative [cnce]
Daunorubicin [antb, orch]
Anthracyclines [antb, orch]
Dosages [qnco]
>90 [qnco]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
Biweekly [tmco]
Little NOS [cgab, dsyn]
activity [dora]
Anthracyclines [antb, orch]
